Nuclear Imaging Devices Market Research Report - Forecast till 2027

Nuclear Imaging Devices Market Research Report: Information by Technology (PET, SPECT (Hybrid SPECT Systems and Standalone SPECT Systems) and Planar Scintigraphy)), Application (Oncology, Cardiology, Neurology and others), End User (Hospitals, Diagnostic Imaging Centers and others) and Region - Forecast till 2027

ID: MRFR/HC/6542-HCR | February 2021 | Region: Global | 90 pages

Nuclear Imaging Devices Market Scenario


The nuclear imaging devices market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.


Nuclear imaging, also known as molecular imaging, is a scanning procedure in which a small amount of radioactive material is injected into a vein, and then pictures are taken with the help of a gamma camera.


The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.


Various other factors such as the advancements in radiotracers, acceptance of nuclear imaging devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on diagnostic imaging centers are also expected to propel the growth of the market.


However, the high cost of the nuclear imaging device, shorter half-life of radiopharmaceuticals can hamper market growth over the forecast period.


Segmentation


The nuclear imaging devices market is segmented based on technology, application, end user, and region.


The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.


Based on application, the market is segmented into oncology, cardiology, neurology, and others.


Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.


In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.


The nuclear imaging devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European nuclear imaging devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The nuclear imaging devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nuclear imaging devices market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players



  • Philips Healthcare

  • General Electric Company

  • Digirad Corporation

  • Neusoft Medical Systems Co., Ltd.

  • Cannon Inc.

  • Surgiceye GmbH

  • CMR Naviscan

  • Mediso Medical Imaging Systems Ltd.

  • Agfa-Gevaert Group

  • DDD-Diagnostic A/S

  • Segamicorp

  • Spectrum Dynamics Medical


Regional Market Summary


Global Nuclear Imaging Devices Market Share (%), by Region, 2018  Nuclear Imaging Devices Market_Image


Sources: MRFR Analysis


The Americas dominated the global market for nuclear imaging devices owing to the rising geriatric population within the region. As per the data suggested by the United Census Bureau, by 2060, the US is projected to grow by 79 million people, from about 326 million today to 404 million. The population is projected to cross the 400-million threshold in 2058. Rising Participation of market players is also strongly impacting the growth of the Americas nuclear imaging devices market. For instance, in 2018, GE Healthcare highlighted the upgradable configuration of Discovery MI at the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Discovery MI is the highest sensitivity digital PET in the industry that helps delivering the vision of precision health, giving personalized, and quantitative data to clinicians.


 In 2018, it was estimated that Europe stood second in the global nuclear imaging market. Technological advancements, along with the availability of funding opportunities in research and innovation, will support market growth. The rising awareness about the nuclear bone scan and radiology nuclear medicine is also boosting the market growth.


Asia-Pacific (APAC) is expected to represent the phenomenal market growth throughout the forecast period due to rising prevalence of chronic conditions, growing awareness about nuclear imaging, and increasing healthcare expenditure. During 2016-2017, Australia spent nearly USD181 billion on health, which is more than USD 7,400 per person and 10% of overall economic activity.


On the other hand, the Middle East and Africa held the least share in the global nuclear imaging devices market due to the low economic development, especially within the African region.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews ( 80%) and secondary research ( 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research

    • Extensive primary research was conducted to gain a deeper insight into the market and industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research

    • Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and commercial study of the nuclear imaging devices market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.




Market Segmentation 


Nuclear Imaging Devices Market, by Technology



  • Positron Emission Tomography (PET)

    • Single Photon-Emission Computed Tomography (SPECT)

    • Hybrid SPECT Systems



  • Standalone SPECT Systems

    • Hybrid Pet

    • Planar Scintigraphy




Nuclear Imaging Devices Market, by Application



  • Oncology

  • Cardiology

  • Neurology

  • Others


Nuclear Imaging Devices Market, by End User



  • Hospitals

  • Diagnostic Imaging Centers

  • Others


Intended Audience



  • Medical devices companies

  • Government and private laboratories

  • Research and development (R&D) companies

  • Research laboratories

  • Market research and consulting service providers



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2018: USD 2490 Million
  • 2027: Significant Value
  •   CAGR   5.2% (2019-2024)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Technology, Application, End user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Philips Healthcare, General Electric Company, Digirad Corporation, Neusoft Medical Systems Co. Ltd., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, DDD-Diagnostic A/S, Segamicorp, Spectrum Dynamics Medical
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Increasing prevalence of cardiovascular disorders
  • Advancements in radiotracers
  • Increasing geriatric population
  • Untapped emerging markets
  • Rise in regulatory approvals
  • Increasing investment on diagnostic imaging centers


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Nuclear Imaging Devices Market was valued at close to USD 2.5 billion in 2018.

    Nuclear Imaging Devices Market is expected to exhibit a strong 5.2% CAGR over the forecast period from 2019 to 2024.

    Nuclear imaging devices are used for the imaging of certain internal organs through the injection of a radioactive tracer.

    The increasing prevalence of cardiovascular diseases is the major driver for the global nuclear imaging devices market.

    The high cost of nuclear imaging devices is the major restraint on the global market.

    Table of Contents

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Macroeconomic Indicators

    4.5 Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Opportunities

    5.4 Pricing Analysis

    Chapter 6. Global Nuclear Imaging Devices Market, by Technology

    6.1 Introduction

    6.2 Positron Emission Tomography (PET)

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Single Photon-Emission Computed Tomography (SPECT)

    6.3.1 Hybrid SPECT Systems

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3.2 Standalone SPECT Systems

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Planar Scintigraphy

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Nuclear Imaging Devices Market, by Application

    7.1 Introduction

    7.2 Oncology

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Cardiology

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 Neurology

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.5 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Nuclear Imaging Devices Market, by End User

    8.1 Introduction

    8.2 Hospitals

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Diagnostic Imaging Centers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Nuclear Imaging Devices Market, by Region

    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 US

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia-Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 South Korea

    9.4.6 Rest of Asia-Pacific

    9.5 Middle East & Africa

    9.5.1 Middle East

    9.5.2 Africa

    Chapter 10. Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    Chapter 11. Company Profiles

    11.1 Philips Healthcare

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials Overview

    11.1.4 Key Developments

    11.1.5 SWOT Analysis

    11.2 General Electric Company

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Digirad Corporation

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Neusoft Medical Systems Co., Ltd.

    11.4.1 Company Overview

    11.4.2 Product Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Cannon Inc.

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.5.5 SWOT Analysis

    11.6 Surgiceye GmbH

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.6.5 SWOT Analysis

    11.7 DDD-Diagnostic A/S

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 CMR Naviscan Corporation

    11.8.1 Overview

    11.8.2 Product Overview

    11.8.3 Financials

    11.8.4 Key Developments

    11.8.5 SWOT Analysis

    11.9 Siemens AG

    11.9.1 Overview

    11.9.2 Product Overview

    11.9.3 Financials

    11.9.4 Key Developments

    11.9.5 SWOT Analysis

    11.10 Mediso Medical Imaging Systems Ltd.

    11.10.1 Overview

    11.10.2 Product Overview

    11.10.3 Financials

    11.10.4 Key Developments

    11.10.5 SWOT Analysis

    11.11 Agfa-Gevaert Group

    11.11.1 Overview

    11.11.2 Product Overview

    11.11.3 Financials

    11.11.4 Key Developments

    11.11.5 SWOT Analysis

    11.12 Segamicorp

    11.12.1 Overview

    11.12.2 Product Overview

    11.12.3 Financials

    11.12.4 Key Developments

    11.12.5 SWOT Analysis

    11.13 Spectrum Dynamics Medical

    11.13.1 Overview

    11.13.2 Product Overview

    11.13.3 Financials

    11.13.4 Key Developments

    11.13.5 SWOT Analysis

    11.14 Other

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s Viewpoint

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Predictions for the Global Nuclear Imaging Devices Market

    Chapter 13 Appendix

    LIST OF TABLES

    Table 1 Nuclear Imaging Devices Market Synopsis, 2020-2027

    Table 2 Nuclear Imaging Devices Market Estimates and Forecast, 2020-2027(USD Million)

    Table 3 Global Nuclear Imaging Devices Market, by Region, 2020-2027(USD Million)

    Table 4 Global Nuclear Imaging Devices Market, by Technology, 2020-2027(USD Million)

    Table 5 Global Nuclear Imaging Devices Market, by Application, 2020-2027(USD Million)

    Table 6 Global Nuclear Imaging Devices Market, End User, 2020-2027(USD Million)

    Table 7 North America: Nuclear Imaging Devices Market, by Technology, 2020-2027(USD Million)

    Table 8 North America: Nuclear Imaging Devices Market, by Application, 2020-2027(USD Million)

    Table 9 North America: Nuclear Imaging Devices Market, End User, 2020-2027(USD Million)

    Table 10 US: Nuclear Imaging Devices Market, by Technology, 2020-2027(USD Million)

    Table 11 US: Nuclear Imaging Devices Market, by Application, 2020-2027(USD Million)

    Table 12 US: Nuclear Imaging Devices Market, End User, 2020-2027(USD Million)

    Table 13 Canada: Nuclear Imaging Devices Market, by Technology, 2020-2027(USD Million)

    Table 14 Canada: Nuclear Imaging Devices Market, by Application, 2020-2027(USD Million)

    Table 15 Canada: Nuclear Imaging Devices Market, End User, 2020-2027(USD Million)

    Table 16 South America: Nuclear Imaging Devices Market, by Technology, 2020-2027(USD Million)

    Table 17 South America: Nuclear Imaging Devices Market, by Application, 2020-2027(USD Million)

    Table 18 South America: Nuclear Imaging Devices Market, End User, 2020-2027(USD Million)

    Table 19 Europe: Nuclear Imaging Devices Market, by Technology, 2020-2027(USD Million)

    Table 20 Europe: Nuclear Imaging Devices Market, by Application, 2020-2027(USD Million)

    Table 21 Europe: Nuclear Imaging Devices Market, End User, 2020-2027(USD Million)

    Table 22 Western Europe: Nuclear Imaging Devices Market, by Technology, 2020-2027(USD Million)

    Table 23 Western Europe: Nuclear Imaging Devices Market, by Application, 2020-2027(USD Million)

    Table 24 Western Europe: Nuclear Imaging Devices Market, by End User, 2020-2027(USD Million)

    Table 25 Eastern Europe: Nuclear Imaging Devices Market, by Technology, 2020-2027(USD Million)

    Table 26 Eastern Europe: Nuclear Imaging Devices Market, by Application, 2020-2027(USD Million)

    Table 27 Eastern Europe: Nuclear Imaging Devices Market, End User, 2020-2027(USD Million)

    Table 28 Asia-Pacific: Nuclear Imaging Devices Market, by Technology, 2020-2027(USD Million)

    Table 29 Asia-Pacific: Nuclear Imaging Devices Market, by Application, 2020-2027(USD Million)

    Table 30 Asia-Pacific: Nuclear Imaging Devices Market, End User, 2020-2027(USD Million)

    Table 31 Middle East & Africa: Nuclear Imaging Devices Market, by Technology, 2020-2027(USD Million)

    Table 32 Middle East & Africa: Nuclear Imaging Devices Market, by Application, 2020-2027(USD Million)

    Table 33 Middle East & Africa: Nuclear Imaging Devices Market, End User, 2020-2027(USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Nuclear Imaging Devices Market

    Figure 3 Market Dynamics for Global Nuclear Imaging Devices Market

    Figure 4 Nuclear Imaging Devices Market Share, by Technology, 2020

    Figure 5 Nuclear Imaging Devices Market Share, by Application, 2020

    Figure 6 Nuclear Imaging Devices Market Share, End User, 2020

    Figure 7 Nuclear Imaging Devices Market Share, by Region, 2020

    Figure 8 North America: Nuclear Imaging Devices Market Share, by Country, 2020

    Figure 9 Europe: Nuclear Imaging Devices Market Share, by Country, 2020

    Figure 10 Asia-Pacific: Nuclear Imaging Devices Market Share, by Country, 2020

    Figure 11 Middle East & Africa: Nuclear Imaging Devices Market Share, by Region, 2020

    Figure 12 Nuclear Imaging Devices Market: Company Share Analysis, 2020 (%)

    Figure 13 Philips Healthcare: Key Financials

    Figure 14 Philips Healthcare: Segmental Revenue

    Figure 15 Philips Healthcare: Geographical Revenue

    Figure 16 General Electric Company: Key Financials

    Figure 17 General Electric Company: Segmental Revenue

    Figure 18 General Electric Company: Geographical Revenue

    Figure 19 Digirad Corporation: Key Financials

    Figure 20 Digirad Corporation: Segmental Revenue

    Figure 21 Digirad Corporation: Geographical Revenue

    Figure 22 Neusoft Medical Systems Co., Ltd.: Key Financials

    Figure 23 Neusoft Medical Systems Co., Ltd.: Segmental Revenue

    Figure 24 Neusoft Medical Systems Co., Ltd.: Geographical Revenue

    Figure 25 Cannon Inc.: Key Financials

    Figure 26 Cannon Inc.: Segmental Revenue

    Figure 27 Cannon Inc.: Geographical Revenue

    Figure 28 Surgiceye GmbH: Key Financials

    Figure 29 Surgiceye GmbH: Segmental Revenue

    Figure 30 Surgiceye GmbH: Geographical Revenue

    Figure 31 CMR Naviscan: Key Financials

    Figure 32 CMR Naviscan: Segmental Revenue

    Figure 33 CMR Naviscan: Geographical Revenue

    Figure 34 Mediso Medical Imaging Systems Ltd.: Key Financials

    Figure 35 Mediso Medical Imaging Systems Ltd.: Segmental Revenue

    Figure 36 Mediso Medical Imaging Systems Ltd.: Geographical Revenue

    Figure 37 Agfa-Gevaert Group: Key Financials

    Figure 38 Agfa-Gevaert Group: Segmental Revenue

    Figure 39 Agfa-Gevaert Group: Geographical Revenue

    Figure 40 DDD-Diagnostic A/S: Key Financials

    Figure 41 DDD-Diagnostic A/S: Segmental Revenue

    Figure 42 DDD-Diagnostic A/S: Geographical Revenue

    Figure 43 Segamicorp: Key Financials

    Figure 44 Segamicorp: Segmental Revenue

    Figure 45 Segamicorp: Geographical Revenue

    Figure 46 Spectrum Dynamics Medical: Key Financials

    Figure 47 Spectrum Dynamics Medical: Segmental Revenue

    Figure 48 Spectrum Dynamics Medical: Geographical Revenue




    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.